240 related articles for article (PubMed ID: 15150080)
1. Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease.
Anderson BE; McNiff JM; Matte C; Athanasiadis I; Shlomchik WD; Shlomchik MJ
Blood; 2004 Sep; 104(5):1565-73. PubMed ID: 15150080
[TBL] [Abstract][Full Text] [Related]
2. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
Edinger M; Hoffmann P; Ermann J; Drago K; Fathman CG; Strober S; Negrin RS
Nat Med; 2003 Sep; 9(9):1144-50. PubMed ID: 12925844
[TBL] [Abstract][Full Text] [Related]
3. Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ.
Anderson BE; McNiff JM; Jain D; Blazar BR; Shlomchik WD; Shlomchik MJ
Blood; 2005 Mar; 105(5):2227-34. PubMed ID: 15522961
[TBL] [Abstract][Full Text] [Related]
4. Regulatory dendritic cells protect against cutaneous chronic graft-versus-host disease mediated through CD4+CD25+Foxp3+ regulatory T cells.
Fujita S; Sato Y; Sato K; Eizumi K; Fukaya T; Kubo M; Yamashita N; Sato K
Blood; 2007 Nov; 110(10):3793-803. PubMed ID: 17687106
[TBL] [Abstract][Full Text] [Related]
5. Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease.
Le Huu D; Matsushita T; Jin G; Hamaguchi Y; Hasegawa M; Takehara K; Tedder TF; Fujimoto M
Blood; 2013 Apr; 121(16):3274-83. PubMed ID: 23422748
[TBL] [Abstract][Full Text] [Related]
6. Target antigens determine graft-versus-host disease phenotype.
Kaplan DH; Anderson BE; McNiff JM; Jain D; Shlomchik MJ; Shlomchik WD
J Immunol; 2004 Nov; 173(9):5467-75. PubMed ID: 15494494
[TBL] [Abstract][Full Text] [Related]
7. Naturally occurring regulatory dendritic cells regulate murine cutaneous chronic graft-versus-host disease.
Sato K; Eizumi K; Fukaya T; Fujita S; Sato Y; Takagi H; Yamamoto M; Yamashita N; Hijikata A; Kitamura H; Ohara O; Yamasaki S; Saito T; Sato K
Blood; 2009 May; 113(19):4780-9. PubMed ID: 19228924
[TBL] [Abstract][Full Text] [Related]
8. Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease.
Zorn E; Kim HT; Lee SJ; Floyd BH; Litsa D; Arumugarajah S; Bellucci R; Alyea EP; Antin JH; Soiffer RJ; Ritz J
Blood; 2005 Oct; 106(8):2903-11. PubMed ID: 15972448
[TBL] [Abstract][Full Text] [Related]
9. CD25+ immunoregulatory T-cells of donor origin suppress alloreactivity after BMT.
Johnson BD; Konkol MC; Truitt RL
Biol Blood Marrow Transplant; 2002; 8(10):525-35. PubMed ID: 12434947
[TBL] [Abstract][Full Text] [Related]
10. Specific donor Vbeta-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens.
Jones SC; Friedman TM; Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2004 Feb; 10(2):91-105. PubMed ID: 14750075
[TBL] [Abstract][Full Text] [Related]
11. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.
Kim W; Kim J; Jung D; Kim H; Choi HJ; Cho HR; Kwon B
Biol Blood Marrow Transplant; 2009 Mar; 15(3):306-14. PubMed ID: 19203721
[TBL] [Abstract][Full Text] [Related]
12. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Sanchez J; Casaño J; Alvarez MA; Roman-Gomez J; Martin C; Martinez F; Gomez P; Serrano J; Herrera C; Torres A
Br J Haematol; 2004 Sep; 126(5):697-703. PubMed ID: 15327522
[TBL] [Abstract][Full Text] [Related]
13. Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma.
Jones MS; Riley R; Hamilton BL; Paupe J; Perez D; Levy RB
Bone Marrow Transplant; 1994 Nov; 14(5):725-35. PubMed ID: 7889005
[TBL] [Abstract][Full Text] [Related]
14. Thymic damage, impaired negative selection, and development of chronic graft-versus-host disease caused by donor CD4+ and CD8+ T cells.
Wu T; Young JS; Johnston H; Ni X; Deng R; Racine J; Wang M; Wang A; Todorov I; Wang J; Zeng D
J Immunol; 2013 Jul; 191(1):488-99. PubMed ID: 23709681
[TBL] [Abstract][Full Text] [Related]
15. Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation.
Hoffmann P; Ermann J; Edinger M; Fathman CG; Strober S
J Exp Med; 2002 Aug; 196(3):389-99. PubMed ID: 12163567
[TBL] [Abstract][Full Text] [Related]
16. Maintenance of CD8+ T-cell anergy by CD4+CD25+ regulatory T cells in chronic graft-versus-host disease.
Kim J; Kim HJ; Choi WS; Nam SH; Cho HR; Kwon B
Exp Mol Med; 2006 Oct; 38(5):494-501. PubMed ID: 17079865
[TBL] [Abstract][Full Text] [Related]
17. Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD.
Ermann J; Hoffmann P; Edinger M; Dutt S; Blankenberg FG; Higgins JP; Negrin RS; Fathman CG; Strober S
Blood; 2005 Mar; 105(5):2220-6. PubMed ID: 15546950
[TBL] [Abstract][Full Text] [Related]
18. CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humans.
Stanzani M; Martins SL; Saliba RM; St John LS; Bryan S; Couriel D; McMannis J; Champlin RE; Molldrem JJ; Komanduri KV
Blood; 2004 Feb; 103(3):1140-6. PubMed ID: 12907445
[TBL] [Abstract][Full Text] [Related]
19. IL-6 blockade attenuates the development of murine sclerodermatous chronic graft-versus-host disease.
Le Huu D; Matsushita T; Jin G; Hamaguchi Y; Hasegawa M; Takehara K; Fujimoto M
J Invest Dermatol; 2012 Dec; 132(12):2752-61. PubMed ID: 22810302
[TBL] [Abstract][Full Text] [Related]
20. Modeling Chronic Graft-versus-Host Disease in MHC-Matched Mouse Strains: Genetics, Graft Composition, and Tissue Targets.
Müller AMS; Min D; Wernig G; Levy RB; Perez VL; Herretes S; Florek M; Burnett C; Weinberg K; Shizuru JA
Biol Blood Marrow Transplant; 2019 Dec; 25(12):2338-2349. PubMed ID: 31415899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]